Cited by 69Cancer, Hypoxia, and MetabolismBiochemical Acid Research StudiesFolate and B Vitamins Research

Glycine decarboxylase maintains mitochondrial protein lipoylation to support tumor growth

Open access
Mukha, Dzmitry, Fokra, Mariam, Feldman, Alona, Sarvin, Boris, Sarvin, Nikita, Nevo-Dinur, Keren, Besser, Elazar, Hallo, Elior +3 more·2022·Cell Metabolism

Abstract

The folic acid cycle mediates the transfer of one-carbon (1C) units to support nucleotide biosynthesis. While the importance of serine as a mitochondrial and cytosolic donor of folate-mediated 1C units in cancer cells has been thoroughly investigated, a potential role of glycine oxidation remains unclear. We developed an approach for quantifying mitochondrial glycine cleavage system (GCS) flux by combining stable and radioactive isotope tracing with computational flux decomposition. We find high GCS flux in hepatocellular carcinoma (HCC), supporting nucleotide biosynthesis. Surprisingly, other than supplying 1C units, we found that GCS is important for maintaining protein lipoylation and mitochondrial activity. Genetic silencing of glycine decarboxylase inhibits the lipoylation and activity of pyruvate dehydrogenase and impairs tumor growth, suggesting a novel drug target for HCC. Considering the physiological role of liver glycine cleavage, our results support the notion that tissue of origin plays an important role in tumor-specific metabolic rewiring.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2022.04.006

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • GLDC is a mitochondrial enzyme that catalyzes the first step of glycine catabolism and is hyperactive in various cancers.

    “glycine decarboxylase (GLDC), a mitochondrial enzyme that catalyzes the first step of glycine catabolism and is hyperactive in various cancers [70–72].”

    From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [70]

    The Results and Discussion section, “Hepatocellular carcinoma has high expression and metabolic flux of GCS” (page unavailable), identifies GLDC as a glycine-cleavage-system subunit and reports high GLDC expression in hepatocellular carcinoma and renal cancer. The paper also reports high glycine-cleavage flux in hepatocellular carcinoma, but high expression does not establish that GLDC is hyperactive across various cancers. Our copy describes mitochondrial glycine catabolism through the system without explicitly identifying GLDC’s reaction as its first step. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mukha, D., Fokra, M., Feldman, A., Sarvin, B., Sarvin, N., Nevo-Dinur, K., Besser, E., Hallo, E., Aizenshtein, E., Schug, Z. T., & Shlomi, T.
Affiliations
  • The Wistar Institute (US)
  • Technion – Israel Institute of Technology (IL)
Corresponding author
Shlomi, Tomer
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2022-05
Volume
34
Issue
5
Pages
775-782.e9
ISSN
1550-4131 (ISSN-L)
OpenAlex
W4225296420
Cited by
69
References
29
Citations by year
2026: 16 · 2025: 22 · 2024: 16 · 2023: 11 · 2022: 4
FWCI
5.69
Type
journal article
Language
en
Open access
Locations
  • Cell Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Gujarat Cancer Society (2H, 2I)
  • National Institutes of Health (NCI DP2 CA249950-01, P30 CA010815)
  • European Research Council (714738)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Biochemical Acid Research Studies
  • Health Sciences › Medicine › Rheumatology › Folate and B Vitamins Research
Keywords
glycine decarboxylase, glycine cleavage system, protein lipoylation, pyruvate dehydrogenase, hepatocellular carcinoma, one-carbon units, nucleotide synthesis, tumor growth, therapeutic target, isotope tracing, flux decomposition
MeSH terms
Folic Acid, Glycine, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Nucleotides, Mitochondrial Proteins, Glycine Dehydrogenase (Decarboxylating), Lipoylation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review